PRAX Q3 2025 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$7B

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$66M

Operating Income

-$78M

Net Income

-$74M

EPS (Diluted)

$-3.36

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$65M

Free Cash Flow

-$65M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$396M

Total Liabilities

$53M

Stockholders' Equity

$344M

Cash & Equivalents

$150M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$302,000	-100.0%
Gross Profit	-$66M	-$42M	-58.2%
Operating Income	-$78M	-$57M	-37.9%
Net Income	-$74M	-$52M	-42.4%